PHAT

PHATHOM PHARMACEUTICALS INC

PHAT·71722W107·US·Common Stock·Healthcare - Biotechnology-Activist

PHAT (PHATHOM PHARMACEUTICALS INC) is held by 101 institutional investors as of Q1 2026. Largest holders: Invesco Ltd. ($48M), BlackRock, Inc. ($45.1M), MILLENNIUM MANAGEMENT LLC ($44.7M). Net institutional sentiment: Mixed.

101
Holders
(8 Elite)
$398.1M
Total Value
64% (104)
Consensus
67 buying - 37 selling
13F: Insider & Congress:
PHATSmart Money Verdict
View all
Held by 101 funds
8 elite
Who's Trading
ActivistMillennium Management LLCMillennium Management LLC5.3%Mar 12, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.7.5%Nov 4, 2025
InsiderBCBreedlove Robert CharlesSell $7KNov 3, 2025
InsiderBCBreedlove Robert CharlesSell $6KSep 5, 2025
ActivistCarlyle Group Inc.Carlyle Group Inc.4.9%Aug 28, 2025
InsiderBCBreedlove Robert CharlesSell $14KJul 16, 2025
ActivistJennison Associates LLCJennison Associates LLC0.0%Jun 9, 2025
ActivistPRUDENTIAL FINANCIAL INCPRUDENTIAL FINANCIAL INC0.0%Jun 6, 2025
InsiderTNTopper James NBuy $15KMay 21, 2025
InsiderTNTopper James NBuy $21KMay 14, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.3M(+10.2%)$48M0.0%-38.75%
32
Increased
4.1M(+14.2%)$45.1M0.0%+43.49%
33
Increased
4M(+93.2%)$44.7M0.0%+17.81%
46
Unchanged
3.5M$38.8M0.4%+60.14%
0
New
2.6M$28.7M0.0%+14.12%
40
Decreased
1.6M(-30.8%)$18.1M0.0%-35.10%
0
Increased
1.4M(+20.6%)$15.4M0.0%+14.68%
34
Increased
1.3M(+0.7%)$14.9M0.1%+17.84%
28
Increased
1.3M(+23.7%)$14.8M0.0%-18.28%
34
New
1.2M$13.4M0.0%+14.12%
39
New
994,504$11M0.0%+14.12%
38
New
860,692$9.6M0.0%+14.12%
38
New
666,029$7.4M0.0%+14.12%
38
Increased
626,196(+59.7%)$7M0.0%+0.32%
39
Increased
482,136(+734.4%)$5.4M0.0%+7.29%
44
Increased
414,956(+16.4%)$4.6M0.0%-33.00%
31
Increased
409,015(+2.8%)$4.5M0.0%-25.92%
28
Increased
383,058(+23.1%)$4.3M0.0%+11.81%
32
Increased
369,052(+97.0%)$4.1M0.0%-5.84%
43
Increased
360,371(+18.4%)$4M0.0%+47.16%
31

Showing 1-20 of 110

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used